Article
Influence of UDP-glucuronosyltransferase polymorphisms on mycophenolate mofetil-induced side effects in kidney transplant patients.
Transplantation proceedings - 1 Apr 2008
Betônico G N, Abbud-Filho M, Goloni-Bertollo E M, Alvarenga M P S, Guillemette C, Villeneuve L, Benoit-Biancamano M-O, Pavarino-Bertelli E C
Abstract excerpt
Mycophenolate mofetil (MMF) is an immunosuppressive prodrug approved for use in transplantation. Its active metabolite, mycophenolic acid, is mainly metabolized by UDP-glucuronosyltransferase (UGT) enzymes. In this study, we retrospectively analyzed 74 kidney transplant patients who had been prescribed MMF as part of their immunosuppression regimen. Polymorphisms in UGT1A8 (-999C > T, codon 255A > G, codon 277G >...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
